113 related articles for article (PubMed ID: 6978173)
21. Malignant lymphomas as tumours of the immune system.
Berard CW; Cossman J; Jaffe ES
Br J Cancer; 1980 Jul; 42(1):1-20. PubMed ID: 7000112
[TBL] [Abstract][Full Text] [Related]
22. Clinical and prognostic significance of the T-B immunological classification of non-Hodgkin's lymphomas.
Ogasawara H; Fujitani T; Mizojiri G; Hattori H
Laryngoscope; 1981 Jan; 91(1):125-32. PubMed ID: 7005580
[TBL] [Abstract][Full Text] [Related]
23. Stable E rosette-forming lymphocytes in the peripheral blood in non-Hodgkin's lymphoma.
Markey GM; Alexander HD; Hayes DM; Robertson JH; Morris TC
Clin Immunol Immunopathol; 1983 Feb; 26(2):162-70. PubMed ID: 6872340
[TBL] [Abstract][Full Text] [Related]
24. Studies on the high- and low-affinity rosette-forming T-lymphocytes in patients with Hodgkin's and non-Hodgkin's lymphoma.
Kadhim S; Rees RC; Potter CW; Walker R; Hancock BW
Eur J Cancer (1965); 1981 May; 17(5):569-75. PubMed ID: 6975211
[No Abstract] [Full Text] [Related]
25. Description of the cells from the lymph nodes of patients with non-Hodgkin's lymphoma according to some B- and T-cell characteristics.
Stathopoulos G; Papamichail M; Holborow EJ; Davies AJ
Br J Exp Pathol; 1977 Feb; 58(1):95-100. PubMed ID: 300026
[TBL] [Abstract][Full Text] [Related]
26. Detection, isolation and functional studies of CD25+ T cells in lymph nodes involved by B-cell non-Hodgkin's lymphomas.
Bonnefoix T; Claret E; Piccinni MP; Jacob MC; Zheng X; Sotto JJ
Scand J Immunol; 1991 Jul; 34(1):91-100. PubMed ID: 2068535
[TBL] [Abstract][Full Text] [Related]
27. Peripheral lymphocyte count and suppopulations of T and B lymphocytes in benign and malignant diseases.
Lee YT
Surg Gynecol Obstet; 1977 Mar; 144(3):435-50. PubMed ID: 300179
[TBL] [Abstract][Full Text] [Related]
28. T and B lymphocytes in non-Hodgkin's lymphoma: a comparison of tumor-derived cells and peripheral blood lymphocytes.
Noguchi S; Bukowski R; Deodhar S; Hewlett JS
Cancer; 1976 May; 37(5):2247-54. PubMed ID: 1083288
[TBL] [Abstract][Full Text] [Related]
29. The cellular content of non Hodgkin lymphomas: a comprehensive analysis using monoclonal antibodies and other surface marker techniques.
Habeshaw JA; Bailey D; Stansfeld AG; Greaves MF
Br J Cancer; 1983 Mar; 47(3):327-51. PubMed ID: 6338896
[TBL] [Abstract][Full Text] [Related]
30. Abnormal immunoregulation in patients with non-Hodgkin's malignant lymphomas. I. Increased helper function of peripheral blood T lymphocytes.
Gajl-Peczalska KJ; Chartrand SL; Bloomfield CD
Clin Immunol Immunopathol; 1982 May; 23(2):366-78. PubMed ID: 6213342
[No Abstract] [Full Text] [Related]
31. T or B cell origin of some non-Hodgkin's lymphomas.
Peter CR; MacKenzie MR; Glassy FJ
Lancet; 1974 Sep; 2(7882):686-9. PubMed ID: 4142961
[No Abstract] [Full Text] [Related]
32. T and B lymphocytes in lymph nodes and spleen of patients with Hodgkin's disease.
Berényi E; Sonkoly I; Pálóczi K; Balázs G; Szegedi G
Neoplasma; 1979; 26(3):307-13. PubMed ID: 394011
[TBL] [Abstract][Full Text] [Related]
33. Immunocompetence and malignant lymphoma: immunologic status before therapy.
Anderson TC; Jones SE; Soehnlen BJ; Moon TE; Griffith K; Stanley P
Cancer; 1981 Dec; 48(12):2702-9. PubMed ID: 6458352
[TBL] [Abstract][Full Text] [Related]
34. The immunologic characterization of 40 extranodal lymphoid infiltrates: usefulness in distinguishing between benign pseudolymphoma and malignant lymphoma.
Knowles DM; Halper JP; Jakobiec FA
Cancer; 1982 Jun; 49(11):2321-35. PubMed ID: 6804083
[TBL] [Abstract][Full Text] [Related]
35. Studies on the use of membrane markers for the differential diagnosis of malignant lymphomas.
Holowiecki J; Lutz D; Baumgartner G; Hanak H; Knapp W
Oncology; 1979; 36(3):139-43. PubMed ID: 314078
[TBL] [Abstract][Full Text] [Related]
36. Malignant lymphoma with dual B and T cell markers. Analysis of the neoplastic cells with monoclonal antibodies directed against T cell subsets.
Aisenberg AC; Bloch KJ; Wilkes BM
J Exp Med; 1981 Nov; 154(5):1709-14. PubMed ID: 6975352
[TBL] [Abstract][Full Text] [Related]
37. Immunologic abnormalities in patients with malignant lymphoproliferative diseases.
Hunter CP; Tannenbaum H; Churchill WH; Moloney WC; Schur PH
J Natl Cancer Inst; 1977 May; 58(5):1185-90. PubMed ID: 323504
[TBL] [Abstract][Full Text] [Related]
38. T-lymphocyte subsets in human lymph nodes: relative increase of OKT-8+ cells in neoplastic and reactive B-cell proliferation.
Ruco LP; Stoppacciaro A; Valtieri M; Uccini S; Vitolo D; Baroni CD
Clin Immunol Immunopathol; 1984 Mar; 30(3):337-45. PubMed ID: 6607799
[TBL] [Abstract][Full Text] [Related]
39. Lymphocyte markers in non-Hodgkin's lymphomas.
Payne SV; Smith JL; Jones DB; Wright DH
Br J Cancer; 1977 Jul; 36(1):57-64. PubMed ID: 329850
[TBL] [Abstract][Full Text] [Related]
40. [Classification of non-Hodgkin's lymphomas on the basis of Morphological and immunological features shared by normal and neoplastic lymphatic cells (author's transl)].
Stein H
Immun Infekt; 1976 Apr; 4(2):52-69. PubMed ID: 1085745
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
